Continuing Biotech Growth in Switzerland, Says Swiss Biotech Industry Report for 2007.The Report, Announced by Partner Organization Greater Zurich Area The European Metropolitan Region of Zurich (EMRZ), also Greater Zurich Area (GZA, German Zürcher Wirtschaftsraum, Metropolregion Zürich AG, Presents Switzerland as a Thriving Location for Biotech and Life Sciences with Excellent Conditions for Business, Investments, IPOs, and R&D in the Sector ZURICH, Switzerland & BOSTON -- In due time for this year's BIO 2007 in Boston, Massachusetts “Boston” redirects here. For other uses, see Boston (disambiguation). Boston is the capital and most populous city of Massachusetts.[3] The largest city in New England, Boston is considered the unofficial economic and cultural center of the entire New , Swiss Biotech, the biotech consortium of Switzerland, has released its annual report 2007. The report, announced by partner organization Greater Zurich Area AG, presents Switzerland as a thriving location for Biotech and Life Sciences with excellent conditions for business, investments, IPOs, and R&D in the sector. The Swiss Biotech Report 2007 gathers the key economic data of the Swiss biotechnology industry for the year 2006. The market indicators suggest that Switzerland continues to be a hotbed hotbed, low, glass-covered frame structure for starting tender plants. It differs from a cold frame only in that the soil is heated—either artificially as by underground electric wiring or steampipes, or naturally with partially fermented stable manure, which for biotech and life sciences. The sector's sustained growth marks the increasing significance of biotech and life sciences as a driving and innovative force in Swiss economic growth. Swiss Biotech represents currently 218 Swiss biotech companies, divided into 79 core biotech developer companies and 58 extended biotech developer companies, as well as 81 biotech suppliers, excluding multinational pharma subsidiaries. Of the 137 Swiss biotech development companies, 85% are active in so-called "red" biotechnology (human and veterinary medicine veterinary medicine, diagnosis and treatment of diseases of animals. An early interest in animal diseases is found in ancient Greek writings on medicine. Veterinary medicine began to achieve the stature of a science with the organization of the first school in the ), 7% in environmental and industry processes ("white" biotechnology) and 8% in agriculture and food ("green" biotechnology). Swiss biotech industry results The following are among the key findings and figures in the Biotech Report: * Industry turnover for 2006 was CHF CHF In currencies, this is the abbreviation for the Swiss Franc. Notes: The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion. 6,424 million (2005: CHF 5,961 million, i.e. +7.8%); * Swiss biotech had approx. 15,000 employees; * R&D investment by private and listed companies was CHF 1,600 million (2005: CHF 1,533 million, i.e. +4.4%); * Swiss Biotech in 2006 achieved a combined CHF 917 million profit; * SWX Swiss Exchange SWX Swiss Exchange An all-electronic securities exchange formed from the 1995 merger of exchanges in Geneva, Basel, and Zurich. The exchange offers trading in equity securities, investment funds, exchange-traded funds, bonds, Eurobonds, and options. saw 28% growth for SXI LIFE SCIENCES[R] and SXI Bio+Medtech indices; * Equity capital influx amounts to CHF 224 million (2005: CHF 177 million (excl. Speedel pre-IPO financing)); * Close ties between business and academic worlds: 70% of R&D contributions is made by Swiss universities (e.g. ETH Zurich “ETH” redirects here. For other uses, see ETH (disambiguation). The ETH is an internationally oriented university. It is a founding member of the IDEA League and the International Alliance of Research Universities IARU. , EPFL EPFL Ecole Polytechnique Fédérale de Lausanne (French: Swiss Federal Institute of Technology, Lausanne, Switzerland) EPFL Enoch Pratt Free Library (Baltimore, Maryland) EPFL European Professional Football Leagues Lausanne, and University of Zurich History The University of Zurich was founded in 1833 with existing colleges of theology (founded by Huldrych Zwingli in 1525), law and medicine merged together with a new faculty of Philosophy. ); * Swiss biotech has sophisticated means of technology transfer available (e.g. the "SystemsX" initiative and the advanced Swiss biotech network featuring over 40 science parks, think tanks and cooperation alliances). According to the Swiss Biotech Report 2007, the past year has been exceptionally successful for biotech companies in Switzerland. Solid growth for biotech companies in Switzerland Various biotech and pharma start-ups listed on the SWX Swiss Exchange showed impressive overall growth (accounting for both, stock price and private investment): Actelion, well on its way towards its first billion CHF in annual sales even before the company's 10th birthday, achieved 151%; Cytos grew 132%; and Arpida registered a strong result of +93% after a slow start. Basilea (+53%) and Speedel (+18%) also exceeded the Swiss Market Index of +16%. In the past twelve months, three Italian biotech companies, BioXell, Newron Pharmaceuticals and Cosmo Pharmaceuticals, went public on SWX SWX Swiss Exchange (trademark of SWX Swiss Exchange) SWX SolidWorks (3D solid modeling CAD software) SWX Splitter / Wave Division Multiplexer by crossborder listing. Together, the three companies have raised more than EUR EUR In currencies, this is the abbreviation for the Euro. Notes: The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion. 140 million, of which EUR 75 million alone is attributable to the IPO (Initial Public Offering) The first time a company offers shares of stock to the public. While not a computer term per se, many founders, employees and insiders of computer companies have found this acronym more exciting than any tech term they ever heard. of Newron, making it the largest European biotech IPO in 2006. SWX Swiss Exchange has accounted for the largest IPOs in terms of transaction size in Europe for the last three years. About the Greater Zurich Area AG The Greater Zurich Area AG, a nonprofit organization Nonprofit Organization An association that is given tax-free status. Donations to a non-profit organization are often tax deductible as well. Notes: Examples of non-profit organizations are charities, hospitals and schools. , is the marketing association for the Greater Zurich Area business region. It recruits international companies abroad and assists them with setting up companies and making investments in the Greater Zurich Area. Its sponsor is the "Stiftung Greater Zurich Area Standortmarketing," a public-private partnership that was established in November 1998. Since that time, its membership has grown to include the cantons of Aargau, Glarus, Graubunden, Schaffhausen, Schwyz, Solothurn and Zurich, the cities of Zurich and Winterthur, and several businesses. www.greaterzuricharea.ch About Swiss Biotech The Swiss Biotech label was created in order to bolster the Swiss biotech scene at home and abroad and to ensure a uniform image. Swiss Biotech is a consortium of the Swiss biotech regions Bioalps, Biopolo, BaselArea and the Greater Zurich Area. Further members of this marketing alliance are SWX Swiss Exchange and the Swiss Biotech Association. www.swissbiotech.org |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion